Found: 6
Select item for more details and to access through your institution.
Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Peroxisome proliferator-activated receptor alpha down-regulation is associated with enhanced ceramide levels in age-associated cardiac hypertrophy.
- Published in:
- 2007
- By:
- Publication type:
- journal article
PGC-1beta down-regulation is associated with reduced ERRalpha activity and MCAD expression in skeletal muscle of senescence-accelerated mice.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism.
- Published in:
- Diabetologia, 2013, v. 56, n. 6, p. 1372, doi. 10.1007/s00125-013-2867-3
- By:
- Publication type:
- Article
The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
- Published in:
- Diabetologia, 2012, v. 55, n. 3, p. 743, doi. 10.1007/s00125-011-2401-4
- By:
- Publication type:
- Article